– the leading provider of online annual reports to individual and institutional investors.

NeurogesX, Inc.

NeurogesX, Inc., a biopharmaceutical company, focuses on developing and commercializing pain management therapies. Its lead product includes Qutenza (capsaicin) 8% patch, a non-narcotic analgesic formulated dermal delivery system containing an 8% concentration of synthetic capsaicin.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports